If you are a bit overweight or obese, you have some good news. The FDA has changed it’s “deny every weight loss drug policy” and is moving in the right direction.
Ironically, the FDA did not have a single Bariatrician or weight loss doctor on their panel that reviews weight loss medications until recently.
As soon as they have a bariatric doctor on the panel, coincidentally or otherwise, they have two new weight loss medications – Qsymia which is a combination of Phentermine and Topiramate and Belviq (Lorcaserin).
First, the FDA approved Belviq(Lorcaserin) in June of 2012 followed a month later by an approval for Qsymia.
How do Qsymia and Belviq compare?
Here is the information on Qsymia™ (Qsymia is the trade mark of Vivus, Inc.)
W8MD weight loss, sleep and medspa Center’s of America’s unique insurance physician weight loss clinics in greater Philadelphia, NJ and NYC have extensive experience in both the brand name Qsymia™ or the generic combination of Phentermine along with Topiramate (generic version is similar to the brand name although not identical as there no generic equivalent available) for successful weight loss along with Very Low Calorie or Low Calorie Diets, Behavior Modification, and other evidence based measures.
Cost of Qsymia Brand Name Weight Loss Medication
Approximately $275.00 to $300.00 per month at about $5.00 a pill although the manufacturer coupons in eligible patients can bring the cost down to about $150.00 per month.
Cost of the generic combination of Phentermine and Topiramate at W8MD Medical Weight Loss Centers is only $50.00 USD biweekly for both Phentermine and Topirmate at a dollar a pill for a significant cost saving with the generic combination.